Schedule 13G ownership disclosure
CRISPR Therapeutics AG
Security class unavailable · CUSIP: H17182108
Event date: 2020-08-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,519,803
- Percent of class
- 10.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001562230-20-000075
- Form type
- SC 13G
- Filer
- CRISPR Therapeutics AG
- CIK
- CIK 1674416
- Filed
- Sep 10, 2020
- Reporting period
- Aug 31, 2020
- Description
- Schedule 13G beneficial ownership